✦ LIBER ✦

Estramustine affects bone mineral metabolism in metastatic prostate cancer

✍ Scribed by Dennis L. Citrin; Carl-bertil Wallemark; Robert Nadler; Carol Geiger; Kathy Tuttle; Edward H. Kaplan; Walter Hauck

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 556 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19861115)58:10<2208::aid-cncr2820581008>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vinorelbine and estramustine in androgen

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer : A Phase II study

✍ Matthew R. Smith; Donald Kaufman; William Oh; Kimberly Guerin; Michael Seiden; T 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

Nuclear bone imaging in metastatic cance

Nuclear bone imaging in metastatic cancer of the prostate

✍ Jeffrey J. Pollen; Kenneth Gerber; William L. Ashburn; Joseph D. Schmidt 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 956 KB

Prognostic significance of bone metastas

Prognostic significance of bone metastases in patients with metastatic prostate cancer

✍ Kazuo Yamashita; Kakuro Denno; Takafumi Ueda; Yoshio Komatsubara; Toshihiko Kota 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Factors affecting bone mineral density i

Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy

✍ Mayank M. Agarwal; Niranjan Khandelwal; Arup K. Mandal; Satyawati V. Rana; Vivek 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

## Abstract ## BACKGROUND Orchidectomy is an accepted form of androgen‐deprivation therapy (ADT) for prostate carcinoma. Osteoporosis is common in elderly individuals and is accelerated by ADT. The authors studied changes in bone mineral density (BMD) after ADT and factors that affected those chan

Total and regional bone mass and biochem

Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer

✍ Revilla, M.; Arribas, I.; Sanchez-Chapado, M.; Villa, L.F.; Bethencourt, F.; Ric 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

## BACKGROUND. The osteolytic activity of metastases of prostate cancer was evaluted in relation to total body bone mineral content (TBBMC) and regional bone mineral content (RBMC). METHODS. Bone mass was determined by dual-energy X-ray absorptiometry (DXA). Tartrate-resistant acid phosphatase (TR

Denosumab and changes in bone turnover m

Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer

✍ Matthew R Smith; Fred Saad; Blair Egerdie; Paul Sieber; Teuvo LJ Tammela; Benjam 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 127 KB

## Abstract Androgen deprivation therapy (ADT) for prostate cancer increases fracture risk, decreases bone mineral density, and increases bone turnover markers (BTMs) including serum type 1 C‐telopeptide (sCTX), tartrate‐resistant alkaline phosphatase 5b (TRAP‐5b), and procollagen‐1 N‐terminal telo